.
u'\ p , ! ^5 J ^ `q 4 ( v & ,8 J J\ m ڣ 8 P # u5 H Z l ^ j O w ,! 3 E W h { ٞ 6 6 " 8 &L '^ o P ι w p ( : L _ Es E ^ `
+ ;_-* #,##0.00"."_-;\-* #,##0.00"."_-;_-* "-"??"."_-;_-@_- > ;_-* #,##0.00__._-;\-* #,##0.00__._-;_-* "-"??__._-;_-@_- C C C C C C C C C C C C C C C C C C 4 C 4 C C C 4 C
4 C U } m } & } m }
} }
; l 3 : "-" . . : 5024071225 E-mail: ! sales_manager@apteka-k.ru
www.maksal.ru9 1 - 25/04/2008
/ ..
~
?% Evitest PERFECT (Midstream)
~
@^@ ~
@~
@!
Evitest PROOF (Cassette)
~
W@
~
@~
@6 . 260 ( 12 )
~
n@ Aventis-~
?~
@E = "SOS"
~
`@ /~
?~
@
"" 0,5
~
/@
~
.@~
@ 5- 50 N50"
~
S@ LEK - ~
@~
@7 / 9 /. . 150. ~
@ , /-- ~
@~
@4 , 911 ( . )100
~
K@ -~
?~
"@6 . 911 . 100
~
@K@ -~
?~
$@@ 8 911 ( . ) 100
~
M@ -~
@~
&@2 * 911 - 100
~
@ -~
@~
(@, $ 911 / 100
~
@ -~
@~
*@. & 911 / 100
~
@ -~
?~
,@& 911 / 100
~
H@ -~
?~
.@( 911 100
~
Z@ -~
?~
0@/ ' 911 100 .~
ܴ@ -~
?~
1@? 7 Clean&Clear Advantage 150 ~
h@ Johnson & Johnson -~
@~
2@? 7 Clean&Clear Advantage 25 ~
ph@ Johnson & Johnson -~
?~
3@: 2 Clean&Clear 150 ~
h@ Johnson & Johnson -~
?~
4@6 . Clean&Clear 40 ~
h@ Johnson & Johnson -~
?~
5@? 7 Clean&Clear - 150 ~
c@ Johnson & Johnson -~
?~
6@A 9 Clean&Clear . 150 ~
d@ Johnson & Johnson -~
?~
7@: 2 Clean&Clear /. 200 ~
`b@ Johnson & Johnson -~
@ l@ ! @ " @ # @ $ @ % & v ' t @ ( ) x * z + q @ , @ - @ . @ / @ 0 @ 1 @ 2 @ 3 @ 4 @ 5 @ 6 7 @ 8 @ 9 @ : @ ; @ @ ? @ ~
8@: 2 Clean&Clear 200 ~
pe@ Johnson & Johnson -~
?~
! 9@@ ! 8 Clean&Clear 100 ! ~
! d@ ! Johnson & Johnson -~
! ?~
" :@5 " - C . ZETUVIT E 1010
" ~
" "@ " Paul Hartmann~
" 5@~
# ;@5 # - C . ZETUVIT E 1020
# ~
# (@ # Paul Hartmann~
# 4@~
$ @$ & Donat Mg 1
& ~
& R@ & ~
& 4@~
' ?@3 ' + Gillete Sensor Excel / 2
' ~
' h@ ' ~
' ?~
( @@( ( Gillete Slalom Plus 3.
( ~
( P@ ( ~
( ?~
) @@* ) " Gillete Slalom Plus 1.
) ~
) @K@ ) ~
) ?~
* A@! * Gillete Venus 2
* ~
* d@ * ~
* ?~
+ A@> + 6 GILLETTE Fusion /. 200. + ~
+ g@ + ~
+ @~
, B@< , 4 GILLETTE Fusion 200. , ~
, g@ , ~
, ?~
- B@< - 4 GILLETTE Mach3 200. - ~
- @f@ - ~
- ?~
. C@4 . , GILLETTE . 200. . ~
. R@ . ~
. ?~
/ C@- / % GILLETTE 100 / ~
/ @I@ / ~
/ ?~
0 D@. 0 & GILLETTE 200. 0 ~
0 B@ 0 ~
0 ?~
1 D@2 1 * GILLETTE 200. 1 ~
1 R@ 1 ~
1 ?~
2 E@3 2 + GILLETTE 200. 2 ~
2 R@ 2 ~
2 ?~
3 E@5 3 - GILLETTE 200. 3 ~
3 R@ 3 ~
3 ?~
4 F@7 4 / Humer 150 . /. 150 4 ~
4 o@ 4 URGO Laboratoires~
4 @~
5 F@E 5 = Humer 150 . / . . 150 5 ~
5 r@ 5 URGO Laboratoires~
5 ?~
6 G@* 6 " Mennen / 200 6 ~
6 `W@ 6 Colgate palmolive c~
6 ?~
7 G@6 7 . Mennen 24/7 .- 85 7 ~
7 ]@ 7 Colgate palmolive c~
7 ?~
8 H@9 8 1 Mennen 24/7 .- 85 8 ~
8 ]@ 8 Colgate palmolive c~
8 @~
9 H@: 9 2 Mennen 24/7 -. 60 9 ~
9 X@ 9 Colgate palmolive c~
9 ?~
: I@B : : Mennen 24/7 -. 150 : ~
: `T@ : Colgate palmolive c~
: ?~
; I@? ; 7 Mennen 24/7 / 50 ; ~
; `P@ ; Colgate palmolive c~
; ?~
< J@; < 3 Mennen 24/7 50 < ~
< Q@ < Colgate palmolive c~
= 6 Mennen 24/7 50 = ~
= `R@ = Colgate palmolive c~
= @~
> K@> > 6 Mennen Speed Stick - 150. > ~
> U@ > Colgate palmolive c~
> ?~
? K@8 ? 0 Mennen Speed Stick 150 ? ~
? `T@ ? Colgate palmolive c~
? ? @ l@ A @ B @ C @ D @ E @ F @ G @ H I | @ J @ K @ L @ M @ N @ O @ P @ Q @ R @ S @ T @ U @ V @ W @ X @ Y @ Z @ [ @ \ @ ] @ ^ @ _ @ ~
@ L@8 @ 0 Mennen Speed Stick 150 @ ~
@ T@ @ Colgate palmolive c~
@ @~
A L@9 A 1 Mennen Speed Stick . 60 A ~
A S@ A Colgate palmolive c~
A ?~
B M@: B 2 Mennen Speed Stick . 60 B ~
B S@ B Colgate palmolive c~
B ?~
C M@> C 6 Mennen Speed Stick . 60. C ~
C S@ C Colgate palmolive c~
C @~
D N@7 D / Mennen - / 200. D ~
D `W@ D Colgate palmolive c~
D ?~
E N@; E 3 Mennen / 200. E ~
E Y@ E Colgate palmolive c~
E ?~
F O@6 F . Mennen / 21 200. F ~
F V@ F Colgate palmolive c~
F ?~
G O@/ G ' Mennen 50 G ~
G `P@ G Colgate palmolive c~
G ?~
H P@* H " MENALIND-..: 50 H ~
H q@ H Paul Hartmann~
H @~
I @P@C I ; Nuby 200-210 . . .(id4353) I ~
I @ I Nuby by Luvin care~
I ?~
J P@2 J * Nuby 210 .. (id1092) J ~
J @ J Nuby by Luvin care~
J ?~
K P@C K ; Nuby / . (ID730) K ~
K b@ K Nuby by Luvin care~
K ?~
L Q@/ L ' Nuby - . (94002) L ~
L `X@ L Nuby by Luvin care~
L ?~
M @Q@7 M / Nuby . . 2 . (id933) M ~
M @ M Nuby by Luvin care~
M ?~
N Q@@ N 8 Nuby /. 2. N ~
N @ N Nuby by Luvin care~
N ?~
O Q@> O 6 Nuby /. 2. O ~
O @ O Nuby by Luvin care~
O ?~
P R@6 P . OLAY 50.
P ~
P m@ P Procter \ Gamble - ~
P ?~
Q @R@5 Q - OLAY 50.
Q ~
Q m@ Q Procter \ Gamble - ~
Q ?~
R R@B R : OLAY -
R ~
R r@ R Procter \ Gamble - ~
R @~
S R@3 S + OLAY 50
S ~
S r@ S Procter \ Gamble - ~
S @~
T S@/ T ' OLAY 75
T ~
T p@ T Procter \ Gamble - ~
T @~
U @S@3 U + OLAY 15 Total Effects
U ~
U }@ U Procter \ Gamble - ~
U @~
V S@: V 2 OLAY 50.
V ~
V @ V Procter \ Gamble - ~
V @~
W S@9 W 1 OLAY - 75.
W ~
W @ W Procter \ Gamble - ~
W ?~
X T@1 X ) OLAY 150.
X ~
X g@ X Procter \ Gamble - ~
X ?~
Y @T@1 Y ) OLAY 200.
Y ~
Y @h@ Y Procter \ Gamble - ~
Y @~
Z T@1 Z ) OLAY 200.
Z ~
Z e@ Z Procter \ Gamble - ~
Z ?~
[ T@O [ G OLAY - . 50 Total Effects
[ ~
[ @ [ Procter \ Gamble - ~
[ ?~
\ U@8 \ 0 OLAY / 100 Active Hydrating
\ ~
\ g@ \ Procter \ Gamble - ~
\ ?~
] @U@5 ] - OLAY / 15 Age Defying
] ~
] p@ ] Procter \ Gamble - ~
] ?~
^ U@G ^ ? OLAY . /. . 50 Active Hydrating
^ ~
^ h@ ^ Procter \ Gamble - ~
^ @~
_ U@3 _ + OLAY 50 SPF15 Total Effects
_ ~
_ @ _ Procter \ Gamble - ~
_ @ ` l a @ b @ c @ d @ e @ f @ g @ h @ i j k l m n @ o @ p @ q @ r @ s @ t @ u @ v @ w @ x @ y @ z @ { @ | @ } @ ~ @ ~
` V@* ` " OLAY 50 Age Defying
` ~
` @s@ ` Procter \ Gamble - ~
` @~
a @V@A a 9 OLAY /.. 50 Active Hydrating
a ~
a h@ a Procter \ Gamble - ~
a ?~
b V@? b 7 OLAY /. 50 Active Hydrating
b ~
b h@ b Procter \ Gamble - ~
b ?~
c V@6 c . OLAY 50 Total Effects
c ~
c H@ c Procter \ Gamble - ~
c @~
d W@F d > OLAY 50 + 50.+
d ~
d }@ d Procter \ Gamble - ~
d ?~
e @W@@ e 8 OLAY - / 150 Total Effects
e ~
e n@ e Procter \ Gamble - ~
e @~
f W@9 f 1 OLAY 200 Total Effects
f ~
f k@ f Procter \ Gamble - ~
f @~
g W@4 g , OLAY . /.. 200 DC
g ~
g c@ g Procter \ Gamble - ~
g ?~
h X@2 h * OLAY . /. 200 DC
h ~
h c@ h Procter \ Gamble - ~
h ?~
i @X@& i OLAY 250 +
i ~
i @ i Procter \ Gamble - ~
i ?~
j X@- j % OLAY 50 Total Effects
j ~
j @ j Procter \ Gamble - ~
j @~
k X@, k $ OLAY 50 Complete Care
k ~
k m@ k Procter \ Gamble - ~
k ?~
l Y@. l & OLAY 50 Active Hydrating
l ~
l g@ l Procter \ Gamble - ~
l ?~
m @Y@) m ! OLAY 50 Age Defying
m ~
m Ps@ m Procter \ Gamble - ~
m @~
n Y@= n 5 OLAY .//. 28 (.)
n ~
n o@ n Procter \ Gamble - ~
n @~
o Y@ p 6 OLAY ./. 28 (.) DF
p ~
p o@ p Procter \ Gamble - ~
p ?~
q @Z@= q 5 OLAY ./. 28 (.) DF
q ~
q k@ q Procter \ Gamble - ~
q ?~
r Z@4 r , OLAY . / 200 DC
r ~
r 0c@ r Procter \ Gamble - ~
r @~
s Z@1 s ) OLAY 200 Total Effects
s ~
s k@ s Procter \ Gamble - ~
s ?~
t [@9 t 1 OLAY 100 Active Hydrating
t ~
t g@ t Procter \ Gamble - ~
t ?~
u @[@V u N OLAY . 50 Active Hydrating
u ~
u g@ u Procter \ Gamble - ~
u ?~
v [@> v 6 OLAY /. 100 SPF 15 Complete Care
v ~
v 0p@ v Procter \ Gamble - ~
v ?~
w [@> w 6 Palmolive SPA / . w .~
w @V@ w Colgate palmolive c~
w @~
x \@A x 9 Palmolive Thermal SPA - / 250 x .~
x @V@ x Colgate palmolive c~
x ?~
y @\@7 y / Palmolive Thermal SPA / 250 y .~
y @V@ y Colgate palmolive c~
y ?~
z \@5 z - Palmolive / 250. z .~
z @V@ z Colgate palmolive c~
z ?~
{ \@0 { ( Palmolive . - . { .~
{ f@ { Colgate palmolive c~
{ ?~
| ]@1 | ) Palmolive . . . | .~
| `@ | Colgate palmolive c~
| ?~
} @]@1 } ) Palmolive . . . } .~
} `@ } Colgate palmolive c~
} ?~
~ ]@. ~ & Palmolive . . ~ .~
~ @l@ ~ Colgate palmolive c~
~ ?~
]@0 ( Palmolive . . .~
@l@ Colgate palmolive c~
@ l@ @ @ @ @ @ @ @ m o o n q v @ y z @ z } @ } @ u @ @ z x } @ ~
^@E = PALMOLIVTE - 250
~
R@ ~
?~
@^@D 6 //.10+10N2 . -
~
A@ - ~
@~
a@* " //.10+10 .
~
B@ - ~
@~
b@' ./.
~
o@ ~
@~
b@ 15 "
~
0t@ Intendis Manufacturi~
@~
@b@! 0.1% 15 "
~
`t@ Intendis Manufacturi~
@~
`b@% 0.1% 20 "
~
t@ Intendis Manufacturi~
?~
b@( - N250"
~
w@ Novartis - ~
?~
b@( - N250"
~
w@ Novartis C/Sandoz~
@~
b@& - N30
~
J@ Sandoz Private Ltd~
?~
b@' - 0.6 N25" ~
,@ - ~
@ l q l x x k @ @ @ u @ | _ Y @ d g y ~ x @ @ | z @ z @ { @ { @ y w @ { ~
c@ -01-1 ~
r@ Bristol-Myers/~
?~
c@ 0.2 N10
~
@ ~
@~
@c@" .0,25 6 "
~
@ -~
@~
`c@ . / 250 6 ~
@s@ Zentiva Internationa~
@~
c@ .50
~
A@ ~
@~
c@3 + 20 HEEL
~
@ Biologische heilmitt~
?~
c@4 , 15 HEEL
~
@ Biologische heilmitt~
@~
c@ - 0.25 .~
@@ ~
*@~
d@( 10 30."
~
@ Merz GmbH - ~
@~
d@) ! , 0.6 ~
:@ --~
*@~
@d@ 0.6 ~
:@ ~
@~
`d@ / 2 ~
@@@ ~
?~
d@5 - ( ) / 10 .~
V@ Jadran Co - ~
@~
d@- % ( ) 30 .~
@ Jadran Co - ~
$@~
d@" 0.25 ~
<@ ~
(@~
d@ 2 ~
<@ ~
&@~
e@ 10 30."
~
j@ Godecke/Parke-Davis~
@~
e@& 0,064% 15
~
Y@ - ~
?~
@e@ 0,064% 15
~
V@ - ~
@~
`e@; 3 15 /+ -/
~
@X@ - ~
@~
e@ 6 N60 / - -/
~
H@
-~
?~
g@# - N10 . .
~
Z@ Bayer AG - ~
?~
g@% 25 N30"
~
p{@ - ~
@~
h@6 . 0.14 /0.14 10 .75."
~
f@ Baxter Oncology GmbH~
?~
h@ 0.1 N50"
~
@ - ~
?~
@h@ 0.21 10 .
~
@ ~
&@~
`h@ 210 N24 .
~
$@ ~
@~
h@ 50 ~
@ - ~
@~
h@ 250
~
@W@ ~
?~
h@ 125
~
7@ - ~
?~
h@ 50
~
A@ ~
"@~
i@$ . 180 20
~
z@ Berlin-chemie AG - ~
?~
i@ 50+ N60.
~
Q@
-~
@~
@i@ N120.
~
0m@
-~
?~
`i@ N60.
~
w@
-~
@~
i@ N60.
~
e@
-~
?~
i@ / N36 .
~
V@
-~
?~
i@' 60.
~
N@
-~
@~
i@ 60.
~
@
-~
?~
j@! N36.
~
@
-~
@~
j@! N60.
~
``@
-~
?~
@j@ N30.
~
Z@
-~
?~
`j@' 10 / N10 - /"
~
@ Natur product - ~
?~
@q@$ - . 20
~
b@ Natur product - ~
@~
Pq@ - N24
~
@ Natur product - ~
@~
`q@" - 20 . ~
@Z@ - ~
@~
pq@' - 20 . ~
o@ - ~
@ l ! " # $ % & q ' q @ ( | @ ) | * y + h , h - m @ . / v 0 r @ 1 @ 2 3 t 4 p 5 s @ 6 z 7 s 8 { 9 { : ; { ? m @ ~
q@- % . N10../.
~
V@ Natur product - ~
@~
! q@- ! % . N10../.
! ~
! T@ ! Natur product - ~
! @~
" q@% " ../.30
" ~
" h@ " Natur product - ~
" ?~
# q@' # ../ 10
# ~
# S@ # Natur product - ~
# ?~
$ q@' $ ../ 30
$ ~
$ g@ $ Natur product - ~
$ ?~
% q@ % 5 . 2
% ~
% 2@ % ~
% @~
& q@ & 5 . 4
& ~
& D@ & ~
& @~
' q@ ' 180 .20
' ~
' u@ ' Pharmaton Sa - ~
' ?~
( r@ ( 180 .50
( ~
( @ ( Pharmaton Sa - ~
( ?~
) r@ ) 125.
) ~
) {@ ) Boehringer Ingelheim~
) ?~
* r@ * N 5 . * ~
* U@ * Sagmel ~
* ?~
+ 0r@ + 12 . + ~
+ 0@ + Sagmel ~
+ @~
, @r@ , N 5 . , ~
, @ , Sagmel ~
, ?~
- Pr@S - K - - ( )
- ~
- `q@ - ~
- ?~
. `r@ . 20
. ~
. b@ . Esparma - ~
. @~
/ pr@ / 50. / ~
/ c@ / Nepentes Sp.z o.o.~
/ ?~
0 r@= 0 5 . 135 . 0 ~
0 e@ 0 Nepentes Sp.z o.o.~
0 ?~
1 r@5 1 -
1 ~
1 P@ 1
~
1 ?~
2 r@" 2
2 ~
2 @ 2
~
2 @~
3 r@ 3
3 ~
3 X@ 3 ~
3 ?~
4 r@ 4 .
4 ~
4 n@ 4 ~
4 ?~
5 r@ 5 - 50 10
5 ~
5 X@ 5 - ~
5 0@~
6 r@ 6 100 10 .
6 ~
6 g@ 6 ~
6 (@~
7 r@ 7 2% 15
7 ~
7 `@ 7 Polfa\ Jelfa - ~
7 ?~
8 s@ 8 2% 40
8 ~
8 #@ 8 Polfa\ Jelfa - ~
8 ?~
9 s@$ 9 2.5 30 . /"
9 ~
9 @s@ 9 Laboratoire Servier~
9 @~
: s@& : 1.5 30 ."
: ~
: @ : Laboratoire Servier~
: @~
; 0s@$ ; 200 HEEL
; ~
; Py@ ; Biologische heilmitt~
; ?~
< @s@ < / 500 30
< ~
< 0@ < Unipharm Inc - ~
`s@ > 50
> ~
> +@ > ~
> @~
? ps@ ? 5% 50 ? ~
? @ ? Dompe Farmaceutici S~
? ? @ l@ A z @ B @ C u @ D ~ @ E z F v @ G @ H I z J t K e L e M N f @ O P @ Q R x S | T w @ U @ V @ W X @ Y Z } [ t \ t ] x @ ^ _ ~
@ s@" @ . 320 10 @ ~
@ j@ @ Dompe Farmaceutici S~
@ ?~
A s@8 A 0 15% 25 /. . A ~
A r@ A Dompe Farmaceutici S~
A ?~
B s@ B 40
B ~
B ]@ B - ~
B @~
C s@/ C ' 50 / /
C ~
C ^@ C ~
C ?~
D s@/ D ' 50 / /
D ~
D Z@ D ~
D ?~
E s@+ E # 50
E ~
E b@ E ~
E ?~
F s@' F 0.25% - 5 ,"
F ~
F T@ F Ankerpharm GmbH\ Ank~
F @~
G s@' G 0.5% - 5 ,,"
G ~
G
@ G Ankerpharm GmbH\ Ank~
G @~
H t@& H - 220/
H ~
H ;@ H ~
H @~
I t@ I - 50
I ~
I ;@ I ~
I *@~
J t@ J . 1.5 /
J ~
J <@ J ~
J @~
K 0t@ K . 1.5
K ~
K =@ K ~
K @~
L @t@- L % / 10"
L ~
L ]@ L -~
L ?~
M Pt@ M 75
M ~
M b@ M ~
M ?~
N `t@+ N # - + 0.1 N10
N ~
N t@ N - ~
N ?@~
O pt@' O - 0.05 10
O ~
O @ O - ~
O @~
P t@( P - 0.075 10
P ~
P "@ P - ~
P "@~
Q t@' Q - 0.25 10
Q ~
Q `}@ Q -~
Q ?~
R t@# R - 1..1
R ~
R ? R ~
R @~
S t@' S - . 2.5
S ~
S @ S ~
S 7@~
T t@; T 3 - 0.025 10 ()
T ~
T @ T - ~
T 2@~
U t@: U 2 - 0.05 10 ()
U ~
U @ U - ~
U @ k Ratiopharm GmbH - ~
k @~
l @v@ l 50 N30 ."
l ~
l @ l ~
l @~
m Pv@( m 50 30 ."
m ~
m 4@ m ~
m @~
n `v@, n $ 0.1 N30"
n ~
n @ n ~
n @~
o pv@! o .0,2 30 o .~
o @ o - ~
o @~
p v@0 p ( 20/ 200 10. ."
p ~
p w@ p Boehringer Ingelheim~
p @~
q v@ q 1% 1. 10 ."
q ~
q @ q ~
q ?~
r v@- r % 0,457/5 . / 70
r ~
r r@ r Smithkline Beecham p~
r ?~
s v@ s 0.375 N20"
s ~
s ps@ s Smithkline Beecham -~
s @~
t v@ t 0.625 N14"
t ~
t y@ t Smithkline Beecham -~
t @~
u v@ u 0.625 N20"
u ~
u <@ u Smithkline Beecham -~
u ?~
v v@9 v 1 228 /5 . / 70 . "
v ~
v g@ v Smithkline Beecham p~
v ?~
w v@3 w + - ( /)140 w .~
w e@ w ~
w ?~
x w@ x 100 x ~
x h@ x - ~
x ?~
y w@ y 20 .
y ~
y Pb@ y Richard Bittner GmbH~
y @~
z w@ z 50
z ~
z p@ z Richard Bittner GmbH~
z @~
{ 0w@ { 0,01 50 { ~
{ s@ { ~
{ @~
| @w@5 | - ( -) 100. 30 | ~
| A@ | - ~
| ?~
} Pw@5 } - ( -) 300. 30 } ~
} P@ } - ~
} ?~
~ `w@+ ~ # 0.5 N10
~ ~
~ @ ~ ~
~ B@~
pw@% - 5% 5
~
9@ - ~
@ l y y n o y x ^ \ l l s l s r v @ @ @ @ @ @ @ @ @ @ @ @ @ ~
w@! - 0.2 N20"
~
@ - ~
@~
w@! - 0.4 N20"
~
@ - ~
@~
w@! 1 10" ~
D@ ~
@~
w@, $ -100 () 0.1 N20
~
@ Hexal pharma GmbH -~
@~
w@+ # -100 0.1 20
~
-@ Hexal AG - ~
"@~
w@ N30.
~
|@ - ~
?~
w@! 100 N20
~
Pg@ Almirall/Nycomed~
?~
w@) ! / 75
~
:@ -~
@~
x@$ . 50
~
3@ ~
@~
x@ . 0.5 ~
L@ ~
@~
x@ . 1 ~
V@ ~
@~
0x@ 10 .
~
8@ ~
@~
@x@ 20 .
~
E@ ~
?~
Px@ 5 .
~
$@ .- .-.~
?~
`x@ 75
~
P@ +~
@~
px@# 5% 40
~
0w@ Galderma~
?~
x@ N20
~
@ Marion Merrel Dow -~
@~
x@ 100
~
j@ Hoffmann la Roche -~
@~
x@D 6 -. / . . / ( )
~
@`@ ~
?~
x@2 * - / 200
~
@
~
?~
x@N F - . . () ~
g@ ~
@~
x@L D - . . () ~
a@ ~
?~
x@H @ - 250 () ~
@k@ ~
?~
y@; 3 - 4.8 Neutrogena . .RoC ~
`X@ Johnson&Johnson Cons~
@~
y@/ ' FLEXITOL
~
e@ Laderma Pty Ltd (~
?~
y@/ ' FLEXITOL
~
c@ Laderma Pty Ltd (~
?~
0y@H @ SOS . 300 . .~
w@ ~
@~
@y@( 250
~
L@ ~
?~
Py@6 . / /. 400 .~
~@ ~
?~
`y@K C / 6- 15 Neutrogena . .RoC ~
f@ Johnson&Johnson Cons~
@~
py@, $ / Vitaskin lip Brilliant
~
@I@ KRKA - ~
? l ~ @ @ @ @ @ @ @ @ @ @ @ @ @ @ q @ @ o o o o o o o s s s s s ~
y@' / lypsyl 4,2 ~
L@ Lornamed Brands Inc~
@~
y@. & / lypsyl 4,2 ~
K@ Lornamed Brands Inc~
@~
y@M E / . 15 Neutrogena . .RoC ~
pl@ Johnson&Johnson Cons~
@~
y@D < / "EVA NATURA"
~
@W@ /~
?~
y@< 4 ., . SPF-2 ( )
~
Y@ ~
?~
y@L D "" SPF 10
~
V@ /~
@~
y@L D "" SPF 15
~
@Y@ /~
@~
y@K C "" SPF 5
~
@Y@ /~
@~
z@: 2 / "Seni Care" 250
~
b@ Bella TZMO ~
@~
z@? 7 . / . 75 () ~
e@ ~
@~
z@L D .-
~
@Y@ /~
@~
0z@2 * 200 .~
Z@ Colgate palmolive c~
@~
@z@A 9 . 200 .~
`[@ Colgate palmolive c~
?~
Pz@7 / 200 .~
Z@ Colgate palmolive c~
?~
`z@. & 200 .~
\@ Colgate palmolive c~
@~
pz@- % 200. .~
\@ Colgate palmolive c~
@~
z@( - -40 3 ~
0t@
~
?~
z@5 - -- .2(91-105) .
~
P}@ ~
@~
z@. & Tonus 1
~
{@ Tonus Elast~
?~
z@ - 1 ~
h@ Tonus Elast~
?~
z@ - 2 ~
j@ Tonus Elast~
(@~
z@ - 3 ~
f@ Tonus Elast~
?~
z@ - 5 ~
f@ Tonus Elast~
?~
z@ - 6 ~
@ Tonus Elast~
@~
{@ - 7 ~
Pf@ Tonus Elast~
@~
{@ - 8 ~
`f@ Tonus Elast~
@~
{@$ - 1 ~
@g@ Tonus Elast~
@~
0{@$ - 2 ~
`h@ Tonus Elast~
@~
@{@$ - 3 ~
j@ Tonus Elast~
@~
P{@$ - 4 ~
g@ Tonus Elast~
@~
`{@$ - 5 ~
@ Tonus Elast~
@~
p{@$ - 6 ~
`h@ Tonus Elast~
@ l s u u u @ @ @ @ @ y @ y @ { v q q @ @ @ @ z j j j n n n x x x { { s s @ ~
{@$ - 8 ~
j@ Tonus Elast~
?~
{@$ . 2
~
Pu@ ~
?~
{@$ . 3
~
t@ ~
?~
{@$ . 4
~
Pu@ ~
@~
{@/ ' FOSTA .L
~
0@ Special Protectors~
?~
{@/ ' FOSTA .S
~
@|@ Special Protectors~
?~
{@/ ' FOSTA .
~
P|@ Special Protectors~
@~
{@7 / 25 -425 5
~
<@
~
@~
|@0 ( / F-212 2 ~
]@
~
?~
|@0 ( / F-212 3 ~
c@
~
?~
|@2
zip-lock
snr roulements
478
100
frigidaire
dr
775
motorola v3i
939
-
longines
braas
tognana
mastercard
electrolux
dolmar
contiwinterviking
ielts
dr
ubiquam
trinity hi-fi
gislaved
ielts
5004.14 ()
master
-
-
salamander
inerta
-134 .-
fifa 2006
775
metabo
renu multiplus 355
dolmar
-
online
dhl
portofino
sikkens
100
.